Charles River Laboratories International, Inc. Stock News
$147.96
1.53%
today
NYSE,
Sep 24, 08:15 pm CET
Index
Industry
Charles River Laboratories International, Inc. Stock News
Neutral
Business Wire
●
8 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Chief Financial Officer Transition.
Neutral
Business Wire
●
13 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River collaborates to enhance oncology manufacturing portfolio by advancing development of cell and gene therapies to treat cancer.
Neutral
Seeking Alpha
●
14 days ago
Charles River Laboratories International, Inc. (NYSE:CRL ) Baird 2025 Global Healthcare Conference September 10, 2025 9:40 AM EDT Company Participants James Foster - Chairman, President & CEO Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Presentation Eric Coldwell Senior Research Analyst Good morning, everyone.
Neutral
Seeking Alpha
●
15 days ago
Charles River Laboratories International, Inc. (NYSE:CRL ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:00 AM EDT Company Participants James Foster - Chairman, President & CEO Conference Call Participants Kallum Titchmarsh - Morgan Stanley, Research Division Presentation Kallum Titchmarsh Equity Analyst Okay. Great. I think we can get started.
Neutral
Business Wire
●
16 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Baird and Morgan Stanley Conferences.
Neutral
Business Wire
●
21 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Integration of Akadeum's GMP-grade Human T Cell Leukopak Isolation Kit into Charles River's Cell Therapy Flex Program announced today.
Neutral
Business Wire
●
29 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River joins EASYGEN to provide 3D screening expertise, supporting the development of a bedside CAR-T manufacturing platform .
Positive
The Motley Fool
●
about 2 months ago
Charles River (CRL) Q2 EPS Jumps 11%
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
